Introduction to Bispecific Antibodies in Practice

Build foundational knowledge of bispecific antibodies and their safe use in cancer care. Developed by University College London Hospitals NHS Foundation Trust and EL Healthcare Education, this free course connects the science with practical learning on treatment preparation, delivery, monitoring and patient counselling.

Designed for healthcare professionals across the multidisciplinary team, it includes four modules of approximately 30 minutes each, with a certificate on completion.
Write your awesome label here.
May Low
Senior Haematology Pharmacist, University College London Hospitals NHS Foundation Trust
May Low is a Myeloma Specialist Pharmacist and Independent Prescriber at University College London Hospitals NHS Foundation Trust, where she leads the clinical pharmacy service for plasma cell disorders. May is a key contributor to the EMMBRAce (Equity in Multiple Myeloma Bispecific Research and Access) programme and lead author of the UK consensus framework for bispecific antibody implementation. Passionate about helping people through learning, May is actively involved in education and service development, supporting healthcare professionals to confidently integrate novel immunotherapies into clinical practice. Her interests include improving equitable access to innovative therapies and advancing the safe and effective use of emerging treatments in plasma cell disorders.
Chantelle Hughes

Senior Nurse and Team Lead, Cancer Clinical Trials Unit, University College London Hospitals NHS Foundation Trust
Chantelle is a Senior Research Nurse in Haematology, currently leading a team delivering clinical trials for patients with leukaemia and red cell disorders. She was Lead Nurse for the EMMBRAce project, a national quality improvement initiative focused on improving patient access to bispecific antibodies for multiple myeloma. Her research interests centre on supporting patients to better understand their health and care.
Luke Steventon
Data Scientist, Great Ormond Street Hospital
Luke is a Data Scientist at Great Ormond Street Hospital for Children NHS Foundation Trust and a PhD candidate at the UCL School of Pharmacy, specialising in cancer research using large-scale healthcare data. His research explores treatment outcomes, side effects and inequalities affecting patients from different ethnic and socioeconomic backgrounds. His interests include using real-world evidence to better understand the safety and effectiveness of cancer treatments and differences in patient outcomes.
Mairead McErlean
Research Pharmacist, Centre for Medicines Optimisation Research and Education (CMORE), University College London Hospitals NHS Foundation Trust
Mairead is a Research Pharmacist at CMORE, University College London Hospitals NHS Foundation Trust, with extensive clinical experience across NHS organisations and the private sector in London. Her background includes medicines optimisation, medication safety and digitally supported quality improvement. Through her Digital Pioneer Fellowship, she supported the implementation of PINCER, a pharmacist-led intervention that uses information technology to identify and reduce prescribing errors in general practice.

Other
Contributors

  • Dr Pinkie Chambers - Associate Professor in Cancer Pharmacy and Pharmacoepidemiology, University College London
  • Prof Rakesh Popat – Consultant Haematologist & Professor of Haematology, University College London Hospitals NHS Foundation Trust
  • Elizabeth Davies, Consultant Haematology Pharmacist, Manchester University NHS Foundation Trust
  • Baguisari Mandane - Specialist Pharmacist, Haematology Oncology and Aseptic Services, Kings College Hospital NHS Foundation Trust
  • Dr Lydia Lee – Consultant Haematologist, University College London Hospitals NHS Foundation Trust; Associate Professor, UCL Cancer Institute
  • Alex Greenwood – Myeloma Research Clinical Nurse Specialist, University College London Hospitals NHS Foundation Trust
  • Chris Salmen - Specialist Pharmacist - Haematology, The Royal Marsden NHS Foundation Trust
Developed by EL Healthcare Education in collaboration with University College London Hospitals NHS Foundation Trust and clinical experts. Financial support was provided as an Independent Medical Education Grant from J&J Innovative Medicine and Pfizer Limited.

By the end of this course, you will be able to:


  • Explain how bispecific antibodies work and their role in cancer treatment.
  • Describe the patient pathway, from assessment and preparation through step-up dosing, ongoing treatment and follow-up.
  • Identify patient, treatment and practical factors that influence the treatment setting, monitoring and supportive care.
  • Recognise key adverse effects, including cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), hypogammaglobulinaemia and infection.
  • Apply principles of pre-dose assessment, monitoring and timely escalation to practical clinical scenarios.
  • Explain the importance of product-specific guidance and local protocols when initiating treatment or restarting after an interruption.
  • Communicate clear, tailored safety information to patients and carers, including what to expect, symptoms to report urgently and how to access help.

Why should I take this course?

Build a strong foundation in a rapidly developing area of cancer care and understand how your role contributes to the safe delivery of bispecific antibody treatment. Through practical scenarios and activities, you’ll learn to recognise key risks, understand monitoring and escalation, and support clear conversations with patients and carers. The course is free, takes approximately two hours to complete and provides a certificate on completion.

Who is this course for?

This course is for healthcare professionals involved in caring for people receiving bispecific antibody treatment, including nurses, pharmacists, doctors, advanced clinical practitioners and pharmacy technicians. It is also relevant to educators and colleagues working in haematology, oncology, ambulatory care and day units who want to build foundational knowledge of these therapies and their safe use in practice.
Go mobile

This course is available for free on our App

Get the app to access this course anytime, anywhere — and make CPD fit around your busy schedule.
Write your awesome label here.
Created with